Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | Denali Therapeutics Inc. | SATO VICKI L
(Director) |
S | Common Stock | D | 1666 | $18.29 - $18.29 | $30,471 |
| 2024-04-01 | Denali Therapeutics Inc. | Krognes Steve E.
(Director) |
S | Common Stock | D | 92500 | $20.50 - $20.50 | $1,896,250 |
| 2024-03-29 | Denali Therapeutics Inc. | Watts Ryan J.
(President and CEO) |
G | Common Stock | D | 40000 | $0.00 - $0.00 | $0 |
| 2024-02-15 | Denali Therapeutics Inc. | SATO VICKI L
(Director) |
S | Common Stock | D | 1666 | $18.37 - $18.37 | $30,604 |
| 2024-02-13 | Denali Therapeutics Inc. | Krognes Steve E.
(Director) |
S | Common Stock | D | 2750 | $17.29 - $17.29 | $47,547 |
| 2024-02-13 | Denali Therapeutics Inc. | Watts Ryan J.
(President and CEO) |
S | Common Stock | D | 9589 | $17.29 - $17.29 | $165,793 |
| 2024-02-13 | Denali Therapeutics Inc. | Ho Carole
(Chief Medical Officer) |
S | Common Stock | D | 4189 | $17.29 - $17.79 | $73,129 |
| 2024-02-13 | Denali Therapeutics Inc. | Schuth Alexander O.
(COFO and Secretary) |
S | Common Stock | D | 22844 | $17.29 - $17.66 | $402,419 |
| 2024-02-08 | Denali Therapeutics Inc. | Schuth Alexander O.
(COFO and Secretary) |
M | Common Stock | A | 50000 | $0.68 - $0.68 | $34,000 |
| 2024-01-16 | Denali Therapeutics Inc. | SATO VICKI L
(Director) |
S | Common Stock | D | 1666 | $18.42 - $18.42 | $30,687 |
| 2024-01-10 | Denali Therapeutics Inc. | Ho Carole
(Chief Medical Officer) |
S | Common Stock | D | 4668 | $19.02 - $19.02 | $88,785 |
| 2024-01-09 | Denali Therapeutics Inc. | Watts Ryan J.
(President and CEO) |
S | Common Stock | D | 7818 | $19.78 - $19.78 | $154,640 |
| 2024-01-05 | Denali Therapeutics Inc. | Ho Carole
(Chief Medical Officer) |
S | Common Stock | D | 9972 | $19.43 - $19.43 | $193,755 |
| 2024-01-05 | Denali Therapeutics Inc. | Krognes Steve E.
(Director) |
S | Common Stock | D | 3208 | $19.43 - $19.43 | $62,331 |
| 2024-01-05 | Denali Therapeutics Inc. | Schuth Alexander O.
(COFO and Secretary) |
S | Common Stock | D | 9972 | $19.43 - $19.43 | $193,755 |
| 2024-01-05 | Denali Therapeutics Inc. | Watts Ryan J.
(President and CEO) |
S | Common Stock | D | 17483 | $19.43 - $19.43 | $339,694 |
| 2023-11-15 | Denali Therapeutics Inc. | SATO VICKI L
(Director) |
S | Common Stock | D | 1666 | $19.13 - $19.13 | $31,870 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |